US Patent 9,181,544
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
Creative Commons License
This work has been identified with a Creative Commons Public Domain Mark 1.0.
Davidson, Beverly L and Boudreau, Ryan L Therapeutic compounds. US Patent 9,181,544 filed February 13, 2012 and issued November 10, 2015. https://ir.uiowa.edu/patents/648